A Study of MK-3655 in Individuals With Pre-cirrhotic Nonalcoholic Steatohepatitis (NASH) (MK-3655-001)
Clinical trial NCT04583423 · TERMINATED
Trial details
- NCT number
- NCT04583423
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-11
- Primary completion
- 2023-04-13
- Enrollment
- 183
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.